Journal of Alzheimer's disease : JAD
Journal
Overview
publication venue for
-
Prognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau 181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine Learning Approach in the ADNI Cohort?
2024
-
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
2024
-
Remote Associations Between Tau and Cortical Amyloid-β Are Stage-Dependent.
2024
-
Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.
2022
-
Impact of Cigarette Smoking and Its Interaction with Hypertension and Diabetes on Cognitive Function in Older Americans.
2022
-
Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics..
87.
2022
-
Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer's Disease..
82.
2021
-
Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease..
83.
2021
-
In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics..
82.
2021
-
Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial..
83.
2021
-
Topographical Overlapping of the Amyloid-β and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity..
83.
2021
-
Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial..
78.
2020
-
Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and Dementia..
77.
2020
-
Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis..
74.
2020
-
Pre-Diabetes, but not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle-Age..
75.
2020
-
Sex Differences in in vivo Alzheimer's Disease Neuropathology in Late Middle-Aged Hispanics..
74.
2020
-
Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease..
78.
2020
-
Individual Prediction of Behavioral Variant Frontotemporal Dementia Development Using Multivariate Pattern Analysis of Magnetic Resonance Imaging Data..
68.
2019
-
Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function..
68.
2019
-
Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia..
67.
2019
-
Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)..
67.
2019
-
An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1..
66.
2018
-
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms..
61.
2018
-
Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation..
64.
2018
-
Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults..
62.
2018
-
Preserved Structural Network Organization Mediates Pathology Spread in Alzheimer's Disease Spectrum Despite Loss of White Matter Tract Integrity..
65.
2018
-
Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery-20181..
66.
2018
-
A Novel Method for Direct Assessment of Everyday Competence Among Older Adults..
57.
2017
-
Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease..
60.
2017
-
Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer's Disease..
57.
2017
-
Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease..
56.
2017
-
The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease..
55.
2017
-
A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease..
54.
2016
-
Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease..
52.
2016
-
Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease..
49.
2016
-
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study..
48.
2015
-
Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia..
48.
2015
-
Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients..
43.
2015
-
MTHFR Gene Mutations: A Potential Marker of Late-Onset Alzheimer's Disease?.
47.
2015
-
A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients..
38.
2014
-
BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment..
37.
2013
-
Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia..
35.
2013
-
MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes..
33.
2013
-
Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast..
32.
2012
-
Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease..
27.
2011
-
Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease..
27.
2011
-
Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol..
26 Suppl 3.
2011
-
Alzheimer research forum live discussion: mice on trial? Issues in the design of drug studies..
16.
2009
-
Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology..
18.
2009
-
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease..
16.
2009
-
Correlations of disability and biologic alterations in Alzheimer brain and test of significance by a therapeutic trial in humans..
9.
2006
-
Neurotrophin survival signaling mechanisms..
6.
2004
-
Abnormalities in oxidative processes in non-neuronal tissues from patients with Alzheimer's disease..
3.
2001
-
Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease..
3.
2001
-
Introduction to The Special Issue: Novel Molecular Pathways and Therapeutic Challenges in Neurodegenerative Diseases..
94.
2023
-
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
2021
-
An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?
2017
-
Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.
2013
-
γ-Secretase modulator in Alzheimer's disease: shifting the end.
2012
-
Oxidative genome damage and its repair in neurodegenerative diseases: function of transition metals as a double-edged sword.
2011
-
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments.
2010
-
Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.
2010
-
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.
2010
-
Challenges associated with metal chelation therapy in Alzheimer's disease.
2009
-
Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis.
2008
-
Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease.
2024
-
Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.
2018
-
Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.
2016
-
The role of the metabolic lesion in Alzheimer's disease.
2002
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)